Mark Rutledge serves as President and CEO of World Precision Instruments, bringing more than two decades of executive experience in life sciences and diagnostics from prior leadership roles at Sebia, Roche Diagnostics, and GE Healthcare. His leadership philosophy emphasizes inclusive decision-making and talent development, based on the belief that giving teams a voice in shaping and implementing change produces better outcomes and stronger buy-in.
At World Precision Instruments, Rutledge has built a people-centered culture focused on professional growth and work-life balance, helping the company achieve below-industry attrition. He champions continuous learning through peer mentoring and varied development opportunities, while steering the company, a longtime player in animal physiology and drug discovery instrumentation, toward newer preclinical alternatives to animal testing, including organ-on-a-chip technology and other in vitro models that can speed up pharmaceutical development.
